Home Newsfeeds Telsey Advisory Group Maintains Outperform on Grove Collaborative Hldgs, Lowers Price Target to $3

Telsey Advisory Group Maintains Outperform on Grove Collaborative Hldgs, Lowers Price Target to $3

Telsey Advisory Group analyst Dana Telsey maintains Grove Collaborative Hldgs (NYSE:GROV) with a Outperform and lowers the price target from $5 to $3.

byBenzinga Newsdesk

March 9, 2023

1 minute read

Telsey Advisory Group analyst Dana Telsey maintains Grove Collaborative Hldgs (NYSE:GROV) with a Outperform and lowers the price target from $5 to $3.

Wayfair To Rally Over 28%? Here Are 10 Top Analyst Forecasts For Thursday

By Avi Kapoor

April 4, 7:40 AM

Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades and downgrades, please see our analyst ratings page.

ASXC

Dubai’s VARA Cracks Down On Crypto Exchange OPNX, Fines Founders $2.8M

By Murtuza Merchant

August 16, 2:24 PM

Dubai's Virtual Assets Regulatory Authority (VARA) imposed a hefty fine of nearly $2.8 million on cryptocurrency exchange OPNX and its founders.

$FTT

Purple Biotech Q3 EPS $(0.27)

By Bill Haddad

November 8, 8:57 AM

Purple Biotech (NASDAQ:PPBT) reported quarterly losses of $(0.27) per share.

PPBT

Timken Q3 EPS $1.52 Beats $1.33 Estimate, Sales $1.14B Beat $1.09B Estimate

By Benzinga Newsdesk

October 26, 6:53 AM

Timken (NYSE:TKR) reported quarterly adj earnings of $1.52 per share which beat the analyst consensus estimate of $1.33 by 14.29 percent. This is a 28.81 percent increase over earnings of $1.18 per share from the same

TKR

Telsey Advisory Group Maintains Outperform on Grove Collaborative Hldgs, Lowers Price Target to $3

Related Posts

Wayfair To Rally Over 28%? Here Are 10 Top Analyst Forecasts For Thursday

Dubai’s VARA Cracks Down On Crypto Exchange OPNX, Fines Founders $2.8M

Purple Biotech Q3 EPS $(0.27)

Timken Q3 EPS $1.52 Beats $1.33 Estimate, Sales $1.14B Beat $1.09B Estimate